The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
An evaluation of CD133 as a biomarker for malignant transformation of colon polyps.
J. S. Hamdan
No relevant relationships to disclose
F. Saghir
No relevant relationships to disclose
R. Benya
No relevant relationships to disclose
A. Chan
No relevant relationships to disclose
A. Blunier
No relevant relationships to disclose
L. Dunham
No relevant relationships to disclose
G. Guzman
No relevant relationships to disclose
N. Mahmud
No relevant relationships to disclose